Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.
Meta Title: “Synlogic Inc Patent: Genetically Engineered Bacteria for Treating Phenylketonuria
Share this article According to GlobalData’s company profile on Synlogic, Peptide pharmacophores was a key innovation area identified from patents. Synlogic‘s grant share as of